Squarepoint Ops LLC Boosts Stake in Corteva, Inc. $CTVA

Key Points

• Squarepoint Ops increased its Corteva stake by 77.8% in the second quarter, owning 31,790 shares valued at approximately $2.69 million. Institutional investors collectively hold 81.54% of Corteva’s stock.
• Corteva’s outlook includes potential long-term earnings growth and a new crop-protection joint venture with Globachem, but the company also faces a $455 million PFAS settlement with DuPont and Chemours that could pressure cash flow.
• Corteva reported quarterly EPS of $2.30, exceeding estimates, while revenue fell 1.2% year over year. Analysts maintain a “Moderate Buy” consensus with an average price target of $91.50, and the company declared a quarterly dividend of $0.18 per share.

Squarepoint Ops LLC increased its stake in Corteva, Inc. (NYSE:CTVA - Free Report) by 77.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 31,790 shares of the company's stock after purchasing an additional 13,913 shares during the quarter. Squarepoint Ops LLC's holdings in Corteva were worth $2,692,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Brighton Jones LLC boosted its position in shares of Corteva by 307.2% during the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company's stock worth $888,000 after acquiring an additional 11,760 shares during the last quarter. Woodline Partners LP raised its stake in shares of Corteva by 40.3% in the first quarter. Woodline Partners LP now owns 57,919 shares of the company's stock valued at $3,645,000 after acquiring an additional 16,644 shares during the period. EverSource Wealth Advisors LLC raised its position in Corteva by 62.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company's stock worth $191,000 after purchasing an additional 980 shares during the period. Cresset Asset Management LLC raised its holdings in shares of Corteva by 2.6% in the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company's stock worth $526,000 after buying an additional 181 shares during the period. Finally, Jump Financial LLC bought a new stake in shares of Corteva during the second quarter worth $1,464,000. 81.54% of the stock is currently owned by institutional investors.

Key Stories Impacting Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Long-term earnings outlook is constructive: KeyCorp estimates Corteva will earn $4.00 per share in fiscal 2027 and $4.20 in fiscal 2028, above the current-year consensus estimate of $3.72. The forecasts suggest expected earnings growth following 2026, although the firm projects a seasonal loss of $0.33 per share in the third quarter and $0.31 of EPS in the fourth quarter.
• Positive Sentiment: New crop-protection venture: Corteva and Globachem plan to launch a joint venture focused on developing new crop-protection solutions. The partnership could expand Corteva’s product pipeline and support longer-term growth in agricultural inputs. Corteva, Globachem to Launch Joint Venture Focused on New Crop Protection Solutions
• Neutral Sentiment: KeyCorp begins coverage at “sector weight”: The rating is effectively neutral, indicating that KeyCorp does not expect Corteva to materially outperform or underperform its broader sector. The new coverage adds analyst visibility but does not provide a strong near-term catalyst.
• Negative Sentiment: PFAS settlement adds legal costs: Corteva, DuPont and Chemours agreed to pay $455 million to North Carolina and 11 local entities to resolve claims tied to PFAS contamination associated with the Fayetteville Works plant and other historical discharges. One law-firm release described the settlement as $380 million, suggesting differing descriptions of the agreement’s total components. The payment may pressure cash flow and keeps environmental liabilities in focus, although it removes uncertainty related to these specific claims. Chemours, DuPont, Corteva settle North Carolina forever chemicals claims

Corteva Trading Down 0.4%

Shares of CTVA opened at $83.54 on Monday. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $90.97. The stock has a market cap of $55.74 billion, a PE ratio of 55.32, a price-to-earnings-growth ratio of 2.58 and a beta of 0.57. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The firm's fifty day moving average is $83.49 and its two-hundred day moving average is $81.36.

Corteva (NYSE:CTVA - Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, beating analysts' consensus estimates of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. During the same quarter in the prior year, the firm earned $2.20 EPS. Corteva's quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Research analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva's dividend payout ratio (DPR) is currently 47.68%.

Analyst Ratings Changes

A number of analysts recently issued reports on CTVA shares. BMO Capital Markets boosted their price target on Corteva from $95.00 to $100.00 and gave the company an "outperform" rating in a report on Monday, August 3rd. JPMorgan Chase & Co. boosted their price objective on shares of Corteva from $77.00 to $83.00 and gave the stock a "neutral" rating in a research note on Monday, August 3rd. KeyCorp initiated coverage on Corteva in a report on Thursday. They issued a "sector weight" rating for the company. Citigroup boosted their price objective on shares of Corteva from $85.00 to $86.00 and gave the company a "neutral" rating in a report on Monday, August 3rd. Finally, Morgan Stanley increased their price target on shares of Corteva from $84.00 to $95.00 and gave the stock an "overweight" rating in a report on Thursday, May 28th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $91.50.

About Corteva

Corteva, Inc is a global agricultural science company that develops and supplies seed, crop protection and digital agriculture solutions. Its products are designed to help farmers improve crop productivity, manage pests and weeds, and address changing environmental and agricultural conditions.

The company's seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crop varieties marketed under brands such as Pioneer and Brevant. Corteva also provides herbicides, insecticides, fungicides and biological products, including solutions associated with its Enlist weed-control system and other crop protection technologies.

Corteva serves farmers, agricultural retailers and other customers across North America, Latin America, Europe, Asia and other international markets.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.